Xpect Pain Away Extra Strength
- Product NDC
- 42961-234
- 11-digit product format
- 429610234
- Labeler code
- 42961
- Product ID
- 42961-234_b7379830-65bc-4257-8915-b0f14f506e93
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen Aspirin Caffeine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Cintas Corporation
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-07-26
- Substance
- ACETAMINOPHEN; ASPIRIN; CAFFEINE
- Active strength
- 250; 250; 65 mg/1; mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 42961-234 | 42961-234-02 | D | Discontinued by firm | 2026-10-23 | |
| excluded package | package | 42961-234 | 42961-234-03 | D | Discontinued by firm | 2026-10-23 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 42961-234-03 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 42961-234-02 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 42961-234-03 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 42961-234-02 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 42961-234-03 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 42961-234-02 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 42961-234-03 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 42961-234-02 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 42961-234-03 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 42961-234-02 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 42961-234-03 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 42961-234-02 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 42961-234-03 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 42961-234-02 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 42961-234-03 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 42961-234-02 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 42961-234-03 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 42961-234-02 | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Xpect Pain Away Extra Strength
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 250 mg/1 |
| ASPIRIN | 250 mg/1 |
| CAFFEINE | 65 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| R16CO5Y76E | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 308297 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1269d069-afaf-4ca5-b369-f74249a348db | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42961-234-01 | Xpect Pain Away Extra Strength | 2 in 1 PACKAGE | TABLET | 2 | 3 | |
| 42961-234-02 | Xpect Pain Away Extra Strength | 50 in 1 BOX | TABLET | 50 | 3 | |
| 42961-234-03 | Xpect Pain Away Extra Strength | 125 in 1 BOX | TABLET | 125 | 3 | |
| 42961-234-04 | Xpect Pain Away Extra Strength | 40 in 1 BOX | TABLET | 40 | 3 | |
| 42961-234-05 | Xpect Pain Away Extra Strength | 80 in 1 BOX | TABLET | 80 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Good Sense Effervescent Pain Relief | ASPIRIN | Perrigo Direct, Inc. | 103027a7-2f0e-8d8c-e063-6294a90aedc7 | 2024-03-26 | Warnings | M013 |
| rugby infants acetaminophen | ACETAMINOPHEN | Rugby Laboratories | 8aa9ac68-ca61-4163-a876-52034138c1ea | 2024-03-25 | Warnings | M013 |
| Equate Pain Reliever Acetaminophen for Adults 250 mg | ACETAMINOPHEN | Walmart Inc | 08a18481-f029-f01f-e063-6294a90aac65 | 2024-03-21 | Warnings | M013 |
| Equate Pain Reliever Acetaminophen for Adults 250 mg | ACETAMINOPHEN | Walmart Inc | 0d106fa2-2a77-deb2-e063-6394a90a2dac | 2024-03-21 | Warnings | M013 |
| Pain Relief Extra Strength | ACETAMINOPHEN | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | 872c5220-a379-4dc1-b99c-f11ebb82db35 | 2024-03-19 | Warnings | M013 |
| Pain Reliever PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | 79886972-47a4-44c5-a131-1a691a328103 | 2024-03-19 | Warnings | M013 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 5ffcc78d-9163-4cb4-8811-ae9f0142806a | 2024-03-18 | Warnings | M013 |
| ASPIRIN LOW DOSE CHEWABLE ORANGE PAIN RELIEVER | ASPIRIN LOW DOSE CHEWABLE ORANGE PAIN RELIEVER | HF Acquisition Co LLC, DBA HealthFirst | 13e621dc-b2b4-98fd-e063-6394a90acc75 | 2024-03-17 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | CVS PHARMACY, INC | 097a9c98-a092-400d-9600-6797b0b9a50c | 2024-03-15 | Warnings | M013 |
| Excedrin PM Triple Action Caplets and Excedrin Tension Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE, AND DIPHENHYDRAMINE CITRATE | Haleon US Holdings LLC | 978a9d27-6d41-42cb-a193-11314923d2ac | 2024-03-14 | Warnings | M013 |
| Excedrin PM Triple Action Caplets | ACETAMINOPHEN, ASPIRIN (NSAID) AND DIPHENHYDRAMINE CITRATE | Haleon US Holdings LLC | b3812d27-40af-40d7-864a-dfa4ae34cb9e | 2024-03-14 | Warnings | M013 |
| Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Haleon US Holdings LLC | 691b754c-bafc-47e2-a322-cf56245c01f6 | 2024-03-14 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | CVS PHARMACY, INC | fdc80b2a-d7c1-4b3d-9a9b-28182c6320de | 2024-03-14 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | QUALITY CHOICE (Chain Drug Marketing Association) | 2cde052d-22a4-470f-8d6a-7c17061b8ac8 | 2024-03-14 | Warnings | M013 |
| Excedrin Tension Headache | ACETAMINOPHEN, CAFFEINE | Haleon US Holdings LLC | 12c074d1-81ac-47d2-8747-b018cda0058a | 2024-03-13 | Warnings | M013 |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Strive Pharmaceuticals Inc. | 78c12459-3b27-4ed0-943d-520794eb438d | 2024-03-07 | Warnings | M013 |
| Pain Reliever fever Reducer Extra Strength | ACETAMINOPHEN | CVS Pharmacy | 7b5263ad-01b7-4fc5-9384-4da8efe89e35 | 2024-03-06 | Warnings | M013 |
| Excedrin Extra Strength Geltabs | ACETAMINOPHEN, ASPRIN, CAFFEINE | Haleon US Holdings LLC | 11a8439b-0159-4351-b0f5-fe7fad6a33c0 | 2024-03-05 | Warnings | M013 |
| Winco Foods Effervescent Pain Relief | ASPIRIN | Winco Foods, LLC | 128afdd7-a9d1-8957-e063-6294a90af569 | 2024-03-05 | Warnings | M013 |
| Aspirin Low Dose Safety Coated | ASPIRIN | Care One (Retail Business Services, LLC.) | 6659e103-fa03-4de0-af42-d2fbd548a87c | 2024-03-05 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | PSN | 1269d069-afaf-4ca5-b369-f74249a348db | 3 |
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | SCD | 1269d069-afaf-4ca5-b369-f74249a348db | 3 |
| 308297 | APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet | SY | 1269d069-afaf-4ca5-b369-f74249a348db | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 42961-234-01 | 42961023401 | 2 in 1 PACKAGE | Historical | ||||
| 42961-234-02 | 42961023402 | 50 in 1 BOX | Historical | ||||
| 42961-234-03 | 42961023403 | 125 in 1 BOX | Historical | ||||
| 42961-234-04 | 42961023404 | 40 PACKAGE in 1 BOX (42961-234-04) / 2 TABLET in 1 PACKAGE (42961-234-01) | 40 package | 2024-12-27 | No | No | Current |
| 42961-234-05 | 42961023405 | 80 PACKAGE in 1 BOX (42961-234-05) / 2 TABLET in 1 PACKAGE (42961-234-01) | 80 package | 2024-12-27 | No | No | Current |